Vocabria

Vocabria (cabotegravir) is an antiretroviral medication used in HIV treatment and prevention. Administered as an intramuscular injection, it belongs to the integrase inhibitor class. This overview covers general uses and considerations for cabotegravir.

Vocabria (cabotegravir) is primarily used in combination with other antiretrovirals for the treatment of HIV-1 infection in adults. It may also be prescribed as part of pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1. The medication works by blocking integrase, an enzyme HIV needs to multiply. It is not a cure for HIV or AIDS.

Cabotegravir may help reduce viral load when used as part of an HIV treatment regimen. Some people report improved energy levels and daily functioning as their condition stabilizes. Individual responses vary, and effects depend on adherence and combination with other medications.

Store cabotegravir at room temperature away from moisture and heat. Keep out of reach of children and pets. Do not use if the injection appears discolored or contains particles. Inform your healthcare provider about any medical conditions or allergies before starting therapy.

Cabotegravir may interact with other medications, including certain anticonvulsants, antibiotics, and herbal products. Avoid alcohol while using cabotegravir unless advised otherwise by a healthcare professional. Always review your full medication list with a provider to assess potential risks.